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Abstract
This study evaluated the accuracy of four height-based equations: blood pressure to 
height ratio (BPHR), modified BPHR (MBPHR), new modified BPHR (NMBPHR), and 
height-based equations (HBE) for screening elevated BP in children and adolescents 
in the SAYCARE study. We measured height and BP of 829 children and adolescents 
from seven South American cities. Receiving operating curves were used to assess 
formula performance to diagnose elevated BP in comparison to the 2017 clinical 
guideline. Sensitivity, specificity, and positive and negative predictive values (PPV, 
NPV) were calculated for the four screening formulas. The diagnostic agreement 
was evaluated with the kappa coefficient. The HBE equation showed the maximum 
sensitivity (100%) in children, both for boys and girls, and showed the best perfor-
mance results, with a very high NPV (>99%) and high PPV (>60%) except for female 
children (53.8%). In adolescents, the highest sensitivity (100%) was achieved with 
the NMBPHR for both sexes. Kappa coefficients indicated that HBE had the highest 
agreement with the gold standard diagnostic method (between 0.70 and 0.75), except 
for female children (0.57). Simplified methods are friendlier than the percentile gold 
standard tables. The HBE equation showed better performance than the other for-
mulas in this Latin American pediatric population.
2  |    SKAPINO et Al.
1  |  INTRODUC TION
High blood pressure (BP) in children and adolescents is one of the 
main predictive factors of hypertension in adults, a significant risk 
factor for cardiovascular events1; Latin America has the highest 
prevalence in this age-group (23.4%).2 Despite the clinical relevance 
of this condition, hypertension in childhood is under-diagnosed.3 
Several factors contribute to this, one of which is that BP measure-
ment is not often included in routine clinical assessments of these 
age-groups. The procedure to obtain the diagnosis of high BP in 
children is also quite complex.3 As BP varies according to age, sex, 
and height, diagnosis requires the determination of height percen-
tiles and comparison of the systolic BP (SBP) and diastolic BP (DBP) 
with values provided by sex- and age-specific reference values.4 To 
simplify the diagnosis of hypertension in children and adolescents, 
several simple methods have been described for screening elevated 
BP in clinical practice.5 Some of these methods use simplified ta-
bles,6,7 others use cutoff points based on the ratio between BP 
and height,8-11 and some authors have developed age- and height-
based formulas to screen high BP.12,13 Several studies have com-
pared these simplified methods to screen hypertension in youth, 
considering the Fourth Report (2004)14 as the reference method 
and showing different results.8-11 Since the publication of the 2017 
Clinical Practice Guidelines,4 currently the most widely used ap-
proach for diagnosing hypertension in children and adolescents, 
some new simplified tables have been designed,15,16 and the per-
formance of some formulas have been tested: the Blood Pressure 
to Height Ratio (BPHR)17 proposed by Lu and colleagues,18 the 
Modified Blood Pressure to Height Ratio (MBPHR)17,19 proposed 
by Mourato and colleagues,20 the new modified blood pressure to 
height ratio (NMBPHR)17,19 proposed by Ma and colleagues21 and 
the height-based equations (HBE) proposed by Mourato and col-
leagues.13 Although the simplified tables are more comfortable to 
use than the ones in the original guidelines, we consider that the 
application of formulas is less complicated than searching in tables. 
Electronic applications have been developed to avoid consulting so 
many percentile tables, but the usage of electronic devices in Latin 
American countries is often not possible. The aim of this study was, 
therefore, to evaluate the feasibility and accuracy of four height-
based equations (BPHR, MBPHR, NMBPHR, and HBE) for screening 
children and adolescents with elevated BP in the SAYCARE study22 
using the 2017 "Clinical Practice Guideline for Screening and 
Management of High Blood Pressure in Children and Adolescents" 
as the reference method.4
2  |  MATERIAL S AND METHODS
We analyzed data collected in the South American Youth/Child 
Cardiovascular and Environmental (SAYCARE) study. SAYCARE is 
an observational multicenter, feasibility study designed to develop 
valid and reliable indicators to investigate health-related behaviors 
and nutritional status in children and adolescents. The study was 
carried out in seven cities from six countries of South America: 
Buenos Aires (Argentina), Lima (Perú), Medellin (Colombia), 
Montevideo (Uruguay), Santiago (Chile), and São Paulo and Teresina 
(Brazil). The fieldwork was carried out during the academic years of 
2015 and 2016.22
The patients were selected in each city in two steps: (a) 
schools were selected based on the students' age stratified into 
two groups: children (3-10 years) and adolescents (11-18 years) 
and school types (public or private), and (b) random sampling was 
conducted by using student lists. Each sex was represented by 
50% of participants. The sample size was calculated based on the 
experience of other multicenter studies in which feasibility pilot 
studies were previously conducted, and the reliability and validity 
of the used methods were evaluated.23-25 The study's exclusion 
criteria were pregnancy, the inability to complete the question-
naires, and the inability/rejection of the parents, guardians, and/or 
students to sign the informed consent form. A total of 1067 chil-
dren and 495 adolescents were invited to take part in the study. 
After losses and rejections, 521 children and 308 adolescents 
agreed to participate in the anthropometric and blood pressure 
measurements.22
The project followed the ethical standards of the Declaration 
of Helsinki and Good Clinical Practice recommendations. The study 
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was approved by the Ethics Committee of each participating center. 
The volunteer and/or guardian provided fully informed written con-
sent to participate.
2.1  |  Measurements
Height was measured with a portable stadiometer (Cardiomed WSC, 
Paraná, Brazil) to the nearest 0.1 cm, with the patient having bare 
feet and head in the Frankfort plane.
Blood pressure was determined with an Omron HEM-7200 
electronic device with automatic inflation and deflation, os-
cillometric measurement method, and a pressure variation of 
0-299 mm Hg. Because correct measurement requires appro-
priate cuff size to avoid overestimating or underestimating the 
valid BP values,14 three different cuff sizes were used according 
to arm circumference measurements: 12-21 cm (small), 22-32 cm 
(medium), and 33-42 cm (large). Before starting the measurement, 
the automatic device was adequately calibrated with a mercury 
sphygmomanometer. Calibration was done before each collec-
tion with all automatic devices. The validity of the automatic de-
vices used for this study has been already tested and published 
elsewhere.26
The BP measurement was taken on the right arm of seated par-
ticipants, who had their backs resting on the back of a chair, their 
arm resting on a rigid surface at the heart level, and uncrossed feet 
resting on the floor. After 5 minutes of rest, the measurement was 
initiated. Two consecutive measures were performed with a 2-min-
ute interval between them; if the difference between the two 
measurements was >5 mm Hg (either for the SBP or DBP), a third 
measurement was carried out. The BP was established as the mean 
of the two closest readings.
The following height-based equations were tested to determine 
their accuracy in the detection of elevated BP (BP level > P90th) ac-
cording to the 2017 Clinical Practice Guideline for the management 
of High Blood Pressure in Children and Adolescents (considered the 
gold standard)4:
(i) Blood pressure to height ratio (BPHR)18 = BP (mm Hg)/Height (cm)
(ii) Modified BP to height ratio (MBPHR)20 = BP/(Height (cm) + 7 × 
(13 − age in years)
(iii) New modified blood pressure to height ratio (NMBPHR)21 = BP/
(Height (cm) + 3 × (13 − age in years)
(iv) Elevated BP cutoffs from the height-based equations (HBE)13: SBP 
P90th = 70 + 0.3 × height (cm); DBP P90th = 35 + 0.25 × height 
(cm)
Although the new guidelines have defined cutoff points for the 
detection of high BP in adolescents (aligned with the new adult 
guideline to facilitate the management of adolescents with high 
BP27), the percentile tables are more precise, so the formulas were 
compared with the percentile tables.
2.2  |  Statistical analysis
Descriptive statistics for sex, height, BMI, SBP, and DBP for children 
and adolescents were expressed as means ± standard deviation (SD). 
Student's t test was used to compare means between sexes. For 
equations (i), (ii), and (iii), receiver operating curves (ROC) were per-
formed to assess their accuracy as diagnostic tests for elevated SBP 
and DBP in boys and girls, both in children and adolescents. The sex- 
and age-specific optimal thresholds of systolic and diastolic BP were 
determined by the Youden index,28 and the values corresponding to 
the maximum of the Youden index were selected as predictive values 
of elevated BP, either for systolic or diastolic BP. The obtained cutoff 
points from the four equations were then used to classify the children 
as either having elevated BP or not (either SBP or DBP). Next, to com-
pare these equations with the gold standard method for identifica-
tion of elevated BP,4 sensitivity, specificity, positive predictive value 
(PPV), and negative predictive value (NPV) were calculated for the 
four screening methods. The areas under the curve (AUC) and 95% 
confidence interval for the BP to height equations were performed to 
assess the discrimination power of the tests. AUC 0.5, AUC 0.5-0.65, 
and AUC 0.65-1.0 were interpreted as equal to chance, moderately, 
and highly accurate tests, respectively.29 The diagnostic agreement 
between each method and the gold standard method4 was evalu-
ated with the kappa coefficient, categorizing the agreement as poor 
Children (3-10.9 y) Adolescents (11-18 y)
Boys Girls Boys Girls
n 250 271 148 160
Age (y) 6.9 ± 2.3 7.0 ± 2.2 14.7 ± 2.2 14.6 ± 2.1
Height (cm) 120.8 ± 1.5 121.3 ± 1.5 163.0 ± 1.2 156.5 ± 0.7
BMI (kg/m2) 17.7 ± 3.5 17.8 ± 3.6 21.9 ± 4.7 21.5 ± 3.4
SBP (mm Hg) 98 ± 10.0 97 ± 10.0 112 ± 12.0 106 ± 9.0
DBP (mm Hg) 63 ± 7.0 63 ± 7.0 64 ± 8.0 65 ± 7.0
Note: Data are presented as mean ± SD.
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure.
*P value for difference between boys and girls using Student's t test. 
TA B L E  1  Descriptive characteristics of 
the study participants by age-group and 
sex
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(kappa < 0.20), fair (kappa between 0.21 and 0.40), moderate (kappa 
between 0.41 and 0.60), substantial (kappa between 0.61 and 0.80), 
and almost perfect (>0.8).30 All the statistical analyses were done 
using the Statistical Package for the Social Sciences (SPSS Inc, 22.0). 
The statistical significance was set at P < .05.
3  |  RESULTS
A total of 521 children and 308 adolescents were included in the 
present study. Table 1 shows the main characteristics of the study 
population, including body mass index (BMI), SBP, and DBP by age 
and sex. The prevalence of elevated blood pressure (BP > P90th) was 
26.8% in children and 13.6% in adolescents.
Performance of the optimal thresholds to determine high SBP 
and DBP for the equations BPHR, MBPHR, and NMBPHR, both in 
children and adolescents in this study, are shown in Table 2 and 
Figure S1 (the HBE directly determines the threshold for the 90th 
percentile for SBP and DBP). The abilities of these formulas to accu-
rately define elevated BP were assessed by the AUC, which ranged 
from 0.906 to 0.996 for most formulas. The BPHR showed lower 
AUC values in children (but not in adolescents), although they were 
still high values: 0.833 and 0.869 for girls and boys, respectively. 
The AUC of the MBPHR equation showed more differences be-
tween groups, being lower in adolescents. The NMBPHR showed 
high AUC in all groups. Table 2 also shows the sensitivity and spec-
ificity of the cutoff points both for SBP and DBP. In most of the 
formulas, sensitivity was higher than specificity both in children 
and adolescents (74.6%-100%), and it was highest in adolescents 
(reaching 100%).
Table 3 shows the PPV and NPV for the four evaluated equations 
and the sensitivity and specificity of the BP diagnosis using each 
equation. Figure 1 shows the area under the curve for the cutoff 
points of the four equations, compared with the gold standard diag-
nosis (2017 Clinical Practice Guidelines of the American Academic 
of Pediatrics), by age-group and sex.
In children, the HBE equation showed maximum sensitiv-
ity (100%), both for boys and girls, while in adolescents, the 
NMBPHR was the equation with the highest sensitivity (100%), 
also for both sexes. PPV was generally low in all cases, ranging 
from 21.2% to 72.6%. The HBE formula showed the best perfor-
mance results, except for female children, for whom the PPV was 
lower (53.8%). NPV was high both in children and adolescents 
(>90%). Kappa coefficient results indicated that HBE showed the 
highest agreement with the gold standard4 diagnostic method 
(between 0.70 and 0.75), except for female children (0.57). 
The lowest agreement was observed for the MBPHR equation 
(0.20-0.53).
4  |  DISCUSSION
This study evaluated the performance of different available height-
based equations for screening elevated BP in children and adoles-
cents from the SAYCARE study. In this sample of Latin American 
children and adolescents, all of the studied formulas performed well 
in the identification of elevated BP. The HBE equation showed bet-
ter performance than the other formulas in this pediatric population. 
In epidemiology, classification bias is common and can consider-
ably diminish the validity of study results.31 These formulas were 
developed to simplify the screening of elevated BP in children and 
adolescents, avoiding the use of complicated and time-consuming 
percentile tables. Specifically, the 2017 Clinical Practice Guidelines 
of the American Academic of Pediatrics4 entail almost 500 sex-, 
TA B L E  2  Cutoff points and their performance in three height-based equations
SBPHR DBPHR MSBPHR MDBPHR NMSBPHR NMDBPHR
Boys Girls Boys Girls Boys Girls Boys Girls Boys Girls Boys Girls
Children




0.906 (0.865-0.947) 0.933 (0.900-0.966) 0.944 (0.913-0.974) 0.835 (0.779-0.891) 0.929 (0.899-0.958) 0.971 (0.953-0.990) 0.952 (0.925-0.979) 0.983 (0.971-0.995) 0.970 (0.952-0.989)
Cutoff points 0.85 0.84 0.56 0.56 0.64 0.63 0.40 0.41 0.74 0.75 0.48 0.48
Sensitivity (%) 90.6 90.0 0.98 84.9 90.6 100 74.6 92.5 100 100 96.6 96.2
Specificity (%) 72.5 67.3 86.4 80.3 85.8 80.1 78.0 85.3 85.3 86.1 89.5 86.7
Adolescents




0.975 (0.941-1.00) 0.882 (0.819-0.945) 0.852 (0.766-0.939) 0.955 (0.915-0.995) 0.891 (0.823-0.960) 0.955 (0.923-0.987) 0.965 (0.936-0.993) 0.996 (0.987-1.00) 0.971 (0.942-1.00)
Cutoff points 0.74 0.74 0.47 0.48 0.82 0.74 0.49 0.49 0.75 0.76 0.49 0.47
Sensitivity (%) 95.5 100 100 88.9 81.8 100 100 100 100 100 100 100
Specificity (%) 89.7 87.2 98.6 97.4 84.9 59.0 87.9 76.8 83.3 89.9 97.2 88.1
Abbreviations: AUC, area under the curve; BPHR, blood pressure to height ratio; HBE, height-based equation; MBPHR, modified BPHR; NMBPHR,  
new MBPHR; S and D before each formula stand for the abbreviation of Systolic and Diastolic, respectively. Sensitivity and specificity were  
computed for their corresponding optimal cutoff points independently for SBP and DBP in the different formulas.
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age-, and height-specific cutoffs to assess SBP and DBP in children 
and adolescents.
Although there are applications or web sites that can identify 
blood pressure percentiles, inequalities in Internet access and inse-
curity problems in Latin American countries make simplified meth-
ods a quick option to screen high blood pressure in children and 
adolescents.
Many equations had been tested with the 2004 Fourth Report 
of the American Academic of Pediatrics guidelines,14 starting with 
the BPHR developed by Lu and colleagues18 and followed by the 
MBPHR32 and the NMBPHR,21 which improved the performance of 
the first one.
In 2017, the new guidelines4 changed the BP percentile values, 
based on a population that excluded children and adolescents with 
overweight or obesity. This meant a change in the cutoff points for 
all formulas.
Zhang and colleagues17 compared the performance of three 
height-based formulas (BPHR, MBPHR, and NMBHR) in Chinese 
and American children using the 2017 guidelines as the diagnosis 
method. He found that NMBPHR performed better than BPHR 
and MBPHR in both child populations, although the three formu-
las had low PPV (<50%) compared to the gold standard guidelines. 
Our study showed better PPV and similar NPV than the three 
formulas tested by Zhang and colleagues17 in the Chinese and 
American populations. The Kappa coefficient also showed a better 
agreement in most of the formulas in our population. Mourato and 
colleagues19 calculated the new cutoff points for the same three 
height-based formulas using the 2017 guidelines in a population 
of Brazilian and American children aged 8-13 years old. He found 
that the NMBPHR showed better specificity and PPV for the 
screening of high BP in both populations. Our study showed better 
PPV than the three formulas tested by Mourato and colleagues19 
in the Brazilian and American populations. NPV in our population 
was similar to these values in the mentioned study. Based on the 
current 2017 guidelines, this author built a simple height-based 
equation (HBE)13 for the detection of high BP and compared it 
with the previously reported screening methods in the mentioned 
samples of Brazilian and American children. His study showed that 
the HBE had a higher ability to detect high BP and better agree-
ment with the 2017 guidelines than the previous ones. We tested 
all of the mentioned formulas in the SAYCARE Latin American 
children and adolescents, comparing them with the new 2017 
guidelines. All of the equations showed a good performance based 
on the AUC, sensibility, specificity, and NPV. Although the PPV 
values were low in all of the formulas, the HBE equation showed 
the highest PPV (>60%) in both age and sex groups, except for fe-
male children (53.8%). This means that 47% of the female children 
identified as having elevated BP using the HBE equation would 
not actually have elevated BP based on the new guidelines (false 
positives). However, the chances of false positives (low PPV) were 
higher when using the other equations, highlighting the lowest 
PPV values of the MBPHR and NMBPHR among female adoles-
cents. These results involve the need for these children to be more 
closely monitored to confirm or rule out the diagnosis, something 
that may result in unnecessary tests and consequent psychologi-
cal stress for these children and their families. On the other hand, 
the NPV was above 90% for all of the equations and reached 100% 
with the HBE equation for both age and sex groups, except for 
female adolescents, which almost reached this value (99.2%). This 
means that the simplified methods to assess high BP perform well 
when the purpose is to exclude the presence of elevated BP.
When we tested the agreement between the formulas and the 
diagnosis by the 2017 guidelines through the kappa coefficient, the 
HBE formula showed the best agreement, above 70%, although, 
TA B L E  2  Cutoff points and their performance in three height-based equations
SBPHR DBPHR MSBPHR MDBPHR NMSBPHR NMDBPHR
Boys Girls Boys Girls Boys Girls Boys Girls Boys Girls Boys Girls
Children




0.906 (0.865-0.947) 0.933 (0.900-0.966) 0.944 (0.913-0.974) 0.835 (0.779-0.891) 0.929 (0.899-0.958) 0.971 (0.953-0.990) 0.952 (0.925-0.979) 0.983 (0.971-0.995) 0.970 (0.952-0.989)
Cutoff points 0.85 0.84 0.56 0.56 0.64 0.63 0.40 0.41 0.74 0.75 0.48 0.48
Sensitivity (%) 90.6 90.0 0.98 84.9 90.6 100 74.6 92.5 100 100 96.6 96.2
Specificity (%) 72.5 67.3 86.4 80.3 85.8 80.1 78.0 85.3 85.3 86.1 89.5 86.7
Adolescents




0.975 (0.941-1.00) 0.882 (0.819-0.945) 0.852 (0.766-0.939) 0.955 (0.915-0.995) 0.891 (0.823-0.960) 0.955 (0.923-0.987) 0.965 (0.936-0.993) 0.996 (0.987-1.00) 0.971 (0.942-1.00)
Cutoff points 0.74 0.74 0.47 0.48 0.82 0.74 0.49 0.49 0.75 0.76 0.49 0.47
Sensitivity (%) 95.5 100 100 88.9 81.8 100 100 100 100 100 100 100
Specificity (%) 89.7 87.2 98.6 97.4 84.9 59.0 87.9 76.8 83.3 89.9 97.2 88.1
Abbreviations: AUC, area under the curve; BPHR, blood pressure to height ratio; HBE, height-based equation; MBPHR, modified BPHR; NMBPHR,  
new MBPHR; S and D before each formula stand for the abbreviation of Systolic and Diastolic, respectively. Sensitivity and specificity were  
computed for their corresponding optimal cutoff points independently for SBP and DBP in the different formulas.
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again, it was lower in female children. We tried to find possible 
causes for this to happen because, in the rest of the groups (male 
children and adolescents of both sexes), the kappa coefficient per-
formed very well in the HBE formula. These results could be related 
to differences in growth pattern, since pubertal development be-
gins earlier in girls than in boys. In a study carried out with more 
than five thousand Croatian children and adolescents, trunk height 
growth velocity increased in girls and decreased in boys between 7 
and 11 years old. The authors mention that their findings are simi-
lar to others found in several European countries, regardless of the 
mean height of each population.33 In a study about components of 
height and blood pressure in children, published in 2014, the authors 
found that trunk length, but not leg length, was positively related 
to SBP and DBP.34 However, we did not measure the trunk length 
in this study. A possible explanation for the difference in kappa val-
ues between girls and boys in children could be that, in this stage of 
growth, the trunk growth rates differ by sex. 34
The simplified methods are friendlier than the diagnosis percen-
tile tables. The most practical formulas to apply were the BPHR and 
the HBE equations because they do not require age in their calcu-
lation. The BPHR equation involves the calculation of four different 
cutoff points (boys and girls in children and adolescents), whereas 
the HBE formula implies two equations, one for the SBP and one for 
the DBP. It is likely that the HBE formula showed a better perfor-
mance in the present Latin American population given the similar or-
igin (Brazilian and American) of the children from the study in which 
the author designed the equation.13 Compared to the performance 
in the Brazilian population of the mentioned study, the HBE equa-
tion performed equal to or better in our Latin American population.
The use of this equation can be useful in those instances where 
the health professional does not have access to the applications that 
can simplify the diagnosis. The data provided by this research is not 
intended to replace the diagnosis of high blood pressure; it aims to 
facilitate the approach to a diagnosis in those children and adoles-
cents who may be hypertensive.
The present work has few limitations that must be acknowledged, 
we were not working with a representative sample of each of the 
different participating countries, and we did not have information 
F I G U R E  1  Receiver operating characteristic curves with the cutoff points of the four equations in children and adolescents
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regarding comorbidities or use of medication. A strength is that we 
could test the equations using the new 2017 guidelines in a diverse 
population of children and adolescents from seven cities in six Latin 
American countries.
5  |  CONCLUSION
In this Latin American pediatric population, the use of the HBE equa-
tion proved to be a useful tool to screen elevated blood pressure in 
children and adolescents. As it is easy to apply, we encourage health 
professionals and epidemiologists to consider it in their routine clini-
cal assessments and determine which patients require from a closer 
and more thorough evaluation to confirm (or rule out) the diagnosis.
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